Professional Documents
Culture Documents
D work in Physics
By Mmmm
Department of Physics
transmitted in to the synaptic cleft must elicit the same response as does excitation of the presynaptic nerve. Second, the presynaptic nerve terminals must be rich in this substance. The isolation of synaptic vesicles containing putative transmitter is the strongest evidence in this regard. Third, the presynaptic nerve must release the postulated transmitter at the right time and in quantity sufficiently to act on the post synaptic nerve. Several catecholamines meet these criteria. For example norephinephrine is the transmitter at smooth-muscle junctions that are innervated by sympathetic nerve fibers, in contrast with parasympathetic junctions in which acetylcoline in the transmitter. Epinephrine and dopamine are two other catecholamine transmitters. In fact, there catecholmines are synthesized form tyrosine in sympathetic-nerve terminals and in the adrenal gland. The fist step, which is rate limiting, is the hydroxylation of tyrosine to form 3,4-dihydrixyphenylalanine (dopa). This reaction is catalyzed by tyrosine hydroxylase, which is like phenylalanine hydroxylase. Molecular oxygen is activated by tetrahydrobiopterin cofactor. The second step, is the decarboxylation of dopa by dopa decarboxylase, a pyridoxal phosphate enzymine, to yield 3,4dihydrozyphenylethylamine (dopamine). Dopamine is then hydroxylated to norepinephrine by a copper containing hydroxylase. Finally, epinephrine is formed by the methylation of norepinephrine by a transmethylase that utilizes S-adenosylmethionine. Catecholamine neurotransmitters are in activated by methylation of the 3-hydroxyl group of the catachol ring. This reaction is catalyzed by catechol-O-methyltransferase, which uses S-adenosylmethionine as the methyl donar. Alternatively, these neurotransmitters can inactivated by oxidative removal of their amino group by manoamine oxidase. In view of this, the crystal and molecular structure studies of some derivatives of catecholamine have been taken up to understand their medicinal properties. Using single crystal X-ray crystallography, we can study the properties such as activity correlation, conformation of the molecules, hydrogen bonding etc.
References:
1. Metal ions in biological systems, edtited by H.Sigel (New York, Marcel Dekker) 1971-1992. Vols. 1-28. 2. Nair M.S, Arasu P.R., Pillai M.S and Natarajan C. J.Chem. Soc.Dalton Trans, 1993, 917.
3. Nair M.S, Arasu P.R., Oillai M.S and Natarajan C .J.Chem. 20, 1995, 132. 4. Sigel H. IUPAC Co-ordination chemistry 20, edited by D.Banergea (Oxford, Pergamon Press), 1993. 5. Carrlson A, J. Neur suppl, 19, 1983, 153 6. Kiss T. & Gergely.A., J.Inorg.Biochem, 1985, 247. 7. Rao C.N.R, chemical application of IR spectroscopy (Academic Press, New York), 1063. 8. Sira S.M. J. Scient, Ind. Res. 44, 1985, 366. 9. Strange (19920 Brain Biochemistry and brain Disorders, Oxford university press) 10.Cools and Clane (1979) Psychopharmacologia 45 243. 11. Kebabian and calne (1979) Nature 277 93. 12. Sibley and Monsma (1992) Tips 13 61 13. Spano et al (1978) Adv. Biochem.Psychopharmacol. 19 155 14.Civelli et al ((1993) Ann.Rev.Pharmacol.Toxicol. 32 281. 15 .Jarvie and caron (1993) Adv.Drug Res. 60 352. 16. Strange (1996) Adv.Drug Res 28 315 17 .Sugamori et al (1994) Proc.Natl.Acad.sci, USA 91 10536 18 .Demchyshyn et al (1995)J.Biol.chem 270 4005 19 .Feng et al (1996)J.Neurosci 16 3925 20.Donnely et al (1994) Receptors and Cannels 261 21. Baldwin et al (1997) J.Mol.Biol.272 144. 22. Coley et al ( 2000) J.Neurochem. 74 358 23. Giors et al (1989) Nature 342-923 24. Liu et al (2000) Nature 403 274 25. Tiberi and caron (1994) J.Biol.Chem. 269-27925 26. Kazmi et al (2000) Biochemistry 39 3734 27. Neve and Neve (1997) The dopamine Respirators. Humana Press, Totowa, New Jersey. 28. Kulagowaski et al (1996) J. Ded.Chem. 39 1941. 29. Guramand et al (1994) J.Biol.Chem 270 7354